Clinical Kidney Journal 2021 vol 14 3 9981003 doi 101093ckjsfaa056 Advance Access Publication Date 22 June 2020 Original Article O R I G I N A L A R T I C L E Effect altitude mortality endstage renal disease patients hemodialysis Peru Katia BravoJaimes Jose RojasCamayo4 Christian R Mejia5 Sandra Schult6 Ruben Nieto7 Kyra Singh8 Susan Messing8 Juana Hinostroza9 1 Viky Y Loescher2 Carlos CaneloAybar3 1Division Cardiovascular Medicine University Texas Health Science Center Houston Houston TX USA 2Department Radiology Mount Sinai Hospital Miami FL USA 3Institut dInvestigacions Biome diques Sant Pau IIB Sant Pau Cochrane Iberoamerican Center Barcelona Spain 4Instituto Investigaciones la Altura Universidad Peruana Cayetano Heredia Lima Peru 5School Health Sciences Universidad Continental Huancayo Junin Peru 6Instituto Nacional Salud del Nino Lima Peru 7Division Nephrology EsSalud Cusco Cusco Peru 8Department Biostatistics Computational Biology University Rochester Medical Center Rochester NY USA 9EsSalud Centro Nacional Salud Renal Lima Peru Correspondence Katia BravoJaimes Email katiambravojaimesuthtmcedu ABSTRACT Background In Latin America prevalence endstage kidney disease ESKD risen tremendously decade Previous studies suggested receiving dialysis high altitude confers mortality beneﬁts effect demonstrated 2000 m sea level masl developing countries Methods This historical cohort study analyzed medical records Peruvian hemodialysis HD centers located altitudes ranging 44 3827 masl Adult ESKD patients started maintenance HD 2000 2010 included Patients classiﬁed strata based elevation sea level city residence low altitude 2000 masl high altitude cid22000 masl Death cause collected national registries Cox proportional hazards models built Results A total 720 patients enrolled 163 226 resided high altitude The lowaltitude group signiﬁcantly younger likely diabetes glomerulonephritis cause ESKD higher hemoglobin The allcause mortality rate 843 1000 personyears In unadjusted Cox model mortality difference high lowaltitude groups fhazard ratio HR 120 95 conﬁdence interval CI 089162g After multivariable adjustment receiving HD high altitude signiﬁcantly associated higher mortality diabetes cause ESKD signiﬁcantly higher mortality HR 250 95 CI 136459 Conclusions In Peru patients receiving HD high altitudes mortality beneﬁts Keywords altitude anemia chronic hemodialysis chronic hypoxia mortality Received 2592019 Editorial decision 1732020 VC The Authors 2020 Published Oxford University Press behalf ERAEDTA This Open Access article distributed terms Creative Commons Attribution NonCommercial License httpcreativecommonsorg licensesbync40 permits noncommercial reuse distribution reproduction medium provided original work properly cited For commercial reuse contact journalspermissionsoupcom 998 INTRODUCTION Chronic noncommunicable diseases including chronic kidney disease CKD leading cause death developed coun tries impose enormous cost countries Latin America LA 13 Data CKD burden LA scarce studies CKD prevalence high 8 Mexico 4 12 Chile 5 168 Peru 6 Similarly prevalence endstage kidney disease ESKD patients renal replacement therapies RRTs LA substantially increased 119 patients million people pmp 1991 669 patients pmp 2013 7 8 In Peru access RRTs universal benefiting social security EsSalud subsidized insurance Ministry Health 6 In 2010 EsSalud pro vided RRTs 9814 patients Ministry Health provided RRTs 1983 patients 2014 9 These numbers reflect high prevalence ESKD requiring RRT country similar developed regions worldwide Furthermore sup pose increasing unmet need affects large number Peruvians Peru 30 million inhabitants population lives altitudes 2000 m Prior studies shown patients receive dialysis altitude 1828 m sea level masl 15 lower mortality risk 5year followup compared similar patients receive dialysis sea level 10 However study carried USA 04 sample living 1828 masl highest modialysis HD center located 2299 masl 11 Thus little known mortality patients ESKD living higher altitudes especially 2000 masl arterial oxygenation saturation starts decline 12 Therefore study ducted determine effect altitude mortality ESKD patients receiving HD Peru MATERIALS AND METHODS This historical cohort study included patients ESKD HD centers located different altitudes Centro Nacional Salud Renal EsSaludLima Hospital Nivel IV Victor Lazarte Echegaray EsSaludTrujillo sea level Hospital Nivel II Huanuco EsSaludHuanuco 1894 masl Hospital Nivel IV Carlos Alberto Seguin Escobedo EsSaludArequipa 2335 masl Hospital Nivel IV Adolfo Guevara Velasco EsSaludCusco 3400 masl Hospital Nivel III Puno EsSaludPuno 3827 masl All patients initiated maintenance HD 2000 2010 locations 18 years age included Patients died 90 days HD initiation previously received renal transplant peritoneal di alysis excluded The study approved ethics committees Universidad Peruana Cayetano Heredia EsSalud All procedures performed studies involving human participants accordance ethical standards ethics committees EsSalud Cayetano Heredia 1964 Helsinki Declaration later amendments comparable ethical standards Informed consent waived retrospective nature study Using standardized form medical records reviewed gather following information age sex cause ESKD date HD session date followup Death cause outcome collected national registries Altitude affects mortality Peruvian HD patients 999 Patients classified strata based eleva tion sea level city residence low altitude 2000 masl high altitude cid22000 masl A sensitivity analysis lower altitude cutoff 1828 masl formed Medians frequencies patient characteristics calculated elevation group Pearson chisquared Wilcoxon ranksum tests univariate analyses baseline characteristics Cox proportional hazards models assessed time HD death cause strati fying year following patients 5 years dialysis Observations censored end data collection January 1 2012 censure criteria applied following loss followup survival 5 years HD transference HD center outside city renal trans plantation migration peritoneal dialysis followup Patients living low altitude served reference category analyses Cox proportional hazards models employed look unadjusted adjusted associations mortality included altitude age sex cause ESKD interactions cause ESKD altitude A subgroup analysis looked association hemoglobin mortality P values 005 considered statistically significant All analy ses carried SASSTAT software version 94 SAS Institute Cary NC USA Windows 7 platform RESULTS Of 2576 patients started HD 2000 2010 HD centers 720 396 met inclusion criteria Figure 1 In Trujillo Lima Huanuco 774 818 845 incident HD patients enrolled respectively Puno Cusco Arequipa proportions fell 347 333 48 spectively Figure 2 A total 557 774 patients lowaltitude group 72 Trujillo 436 Lima 49 Huanuco 163 226 highaltitude group 37 Arequipa 116 Cusco 10 Puno Baseline characteristics shown Table 1 stratified elevation group Patients lowaltitude group significantly younger likely diabetes glomerulonephritis cause ESKD higher hemoglobin Over median followup 36 years 260 361 deaths overall mortality rate 843 1000 personyears In lowaltitude group 207 372 patients died high altitude group 53 325 died In unadjusted Cox propor tional hazards model highaltitude group trend ward higher mortality statistically significant fhazard ratio HR 120 95 confidence interval CI 089162 P ¼ 0243g Figure 3 In sensitivity analysis lower altitude cutoff 1828 masl highaltitude group significantly higher mortality HR 142 95 CI 107190 P ¼ 0016 Supplementary data In univariate subgroup analysis increased hemoglobin significantly associated lower mortality HR 095 95 CI 087104 P ¼ 0274 An adjusted Cox model Table 2 altitude age sex cause ESKD fit demonstrated highaltitude group higher mortality association reach statistical significance HR 116 95 CI 085158 P ¼ 0360 Similarly women nonsignificant trend higher mortality HR 130 95 CI 100169 P ¼ 0050 Additionally year increase age hazard death increased 4 HR 104 95 CI 103105 P 0001 altitudes A second adjusted Cox model Table 3 altitude age sex interaction cause ESKD altitude level fit 1000 K BravoJaimes et al FIGURE 1 Patient inclusion ﬂowchart showed patients diabetes cause ESKD highaltitude group experience significantly higher mortality HR 250 95 CI 136459 P ¼ 0003 There suggestion true hypertension cause ESKD DISCUSSION This study knowledge examined association altitude mortality patients receiving HD Andes This important altitude levels seen cities ethnic group different living high altitude In fact Andeans lived high altitude 11 000 years developing circulatory respiratory hematological adapta tions compared Tibetan populations higher hemoglobin concentrations lower resting ventilation higher oxygen saturation absence genetic adaptation 13 14 Our sample composed middleaged subjects popu lation relatively younger studies involving maintenance HD 10 Interestingly started HD high altitude significantly older lowaltitude counterparts This agreement prior evidence showing slower CKD progression present high altitude 15 16 However factors lower survival older patients living low altitude significant comorbidities increased availability healthcare resources planned HD initiation settings need considered Substantial mortality rates altitude groups nonsignificant trend higher mortality observed living high altitude adjusted analy sis Our results differ prior findings 10 17 18 showed 18 mortality reduction dialysis patients receiving HD increased altitudes Notably studies conducted mainly Caucasian populations altitudes significantly 2000 masl Our results potentially explained myriad factors including magnitude altitude level genetic adaptation variances spe cific patient population comorbid conditions healthcare associated factors social disparities Erythropoietin use differ different Peruvian centers noted lower hemoglobin levels highaltitude group FIGURE 2 Map Peru displaying location participating cit ies according altitude level number incident HD patients number patients included study Map source Wikimedia Commons Table 1 Baseline characteristics elevation group Altitude affects mortality Peruvian HD patients 1001 prone deleterious effects anemia hypoxic environment Additionally study raises concern potential sex dis parity Peruvian patients receiving HD altitude levels women nonsignificant increase hazard death 30 A similar observation documented Caucasian Asian populations receiving HD potential reasons include longer waiting times HD initiation greater loss residual renal function lower urea clearance adjusted urea volume KtVurea shorter HD sessions 19 Moreover higher mortality subjects diabetes receiving HD high altitude Regarding previ ously described independent association higher alti tude worsening hypoxemia increased cardiometabolic risk factors 20 possible higher mortality strongly influenced cardiovascular disease Future studies needed explore association accounting potential confounders Our study performed patients social security ensure access healthcare guideline uniformity However account specific differences way healthcare delivered center staffing needs medication availability Furthermore Andeans lifestyle stress levels different coastal peers impacting mortality outcomes Indirect data support existence regional differences include gross domestic product cap ita Lima Arequipa Trujillo US16313073 higher Cusco Puno Huanuco US6811228 21 life expectancy Lima Arequipa Trujillo 741784 years higher Huanuco Puno Cusco 643685 years 22 human develop ment index higher Lima Arequipa intermediate Trujillo lower Huanuco Cusco Puno 23 number university hospitals offering nephrology training Lima Arequipa Cusco Trujillo Huanuco Puno 24 proportion Quechua ethnicity higher Cusco Puno Huanuco 431747 Arequipa Lima Trujillo 29313 25 This study limitations Our highaltitude group size comparatively small clustering altitude levels performed The percentage incident HD patients enrolled Arequipa 10 missing Variable Age years median rangea Sex n bc Men Women Cause ESKD n b Hypertension Diabetes Glomerulonephritis Other Undetermined Mixed Not ﬁled Hemoglobin gdL median rangead Followup years median range Low altitude n ¼ 557 High altitude n ¼ 163 518 181944 568 182983 297 612 188 388 172 309 119 214 86 154 88 158 13 23 2 04 77 138 90 40164 39 0350 104 638 59 362 52 319 24 147 12 74 21 129 10 61 12 74 32 196 83 36187 24 0250 Pvalue 0001 0559 0001 0009 0001 aWilcoxon ranksum test bChisquared test cInformation available 648 records dBaseline hemoglobin determined 54 patients 309 patients lowaltitude group 86 patients highaltitude group 1002 K BravoJaimes et al FIGURE 3 Survival plot displays estimated survival time patients low high altitude number subjects risk 0 1000 2000 3000 4000 days Patients high altitude nonsigniﬁcant trend lower survival unadjusted analysis ACKNOWLEDGEMENTS Special thanks International Society Nephrology supported research Global Outreach Prevention Program We recognize support following nephrologists Myriam Fiestas Jose Taypicahuana Jose Figueroa Rau l Hinojosa Jhony Paredes Silva Nancy Garcıa FUNDING This study supported grant International Society Nephrology Global Outreach Research Prevention Program CONFLICT OF INTEREST STATEMENT The authors conﬂicts The results pre sented article published previously abstract format Table 2 Adjusted mortality HRs Peruvian patients receiving HD Variable HR 95 CI Pvalue REFERENCES High versus low altitude Age 1year increase Sex women versus men Cause ESKD Diabetes versus othera Hypertension versus otherb 116 085158 104 103105 130 100169 101 098110 120 086169 123 091166 0360 0001 0050 0693 0290 0186 aWhen compared causes ESKD hypertension bWhen compared causes ESKD diabetes Table 3 Adjusted mortality HRs altitude cause ESKD teraction Peruvian patients receiving HD Variable HR 95 CI Pvalue Age 1year increase Sex women versus men Interaction altitude sex Interaction altitude cause ESKD High versus low altitude diabetes 250 136459 High versus low altitude hypertension 115 071189 104 103105 0001 0091 126 096163 0571 083 044158 0014 0003 0567 charts 71 Cusco proportion 35 high incidence acute kidney injury 26 The differences observed results uncontrolled patient characteristics environmental factors correlated altitude independent effect altitude Moreover comor bid conditions medication use including erythropoietin ana logs nutritional status dialysis efficiency KtV residual renal function variably reported paper charts times missing mortality adjusted Cox proportional models In conclusion Peruvian patients receiving HD high alti tudes mortality benefits SUPPLEMENTARY DATA Supplementary data available ckj online 1 Barreto SM Miranda JJ Figueroa JP et al Epidemiology Latin America Caribbean current situation challenges Int J Epidemiol 2012 41 557571 2 Mathers CD Boerma T Ma Fat D Global regional causes death Br Med Bull 2009 92 732 3 Cusumano AM Gonzalez Bedat MC Chronic kidney disease Latin America time improve screening detection Clin J Am Soc Nephrol 2008 3 594600 4 Amato D AlvarezAguilar C CastanedaLimones R et al Prevalence chronic kidney disease urban Mexican population Kidney Int Suppl 2005 68 S11S17 5 Zuniga SMC Muller OH Flores OM Prevalence chronic kidney disease subjects consulting urban primary care clinics Rev Med Chil 2011 139 11761184 Francis ER Kuo CC BernabeOrtiz A et al Burden chronic kidney disease resourcelimited settings Peru populationbased study BMC Nephrol 2015 16 114 6 7 RosaDiez G GonzalezBedat M PecoitsFilho R et al Renal replacement therapy Latin American endstage renal dis ease Clin Kidney J 2014 7 431436 8 Cusumano AM RosaDiez GJ GonzalezBedat MC Latin American dialysis transplant registry experience contributions endstage renal disease epidemiology World J Nephrol 2016 5 389397 9 HerreraAnazco P BenitesZapata VA HuarcayaCotaquispe LYI et al Chronic kidney disease Peru challenge country emerging economy J Bras Nefrol 2015 37 507508 10 Winkelmayer WC Liu J Brookhart MA Altitude cause mortality incident dialysis patients JAMA 2009 301 508512 11 Centers Medicare Medicaid Services Dialysis Facilities US httpsdatamedicaregovDialysisFacility 23 CompareDialysisFacilitiesintheUSkwkmuxp2 February 2020 date accessed 12 RojasCamayo J Mejia CR Callacondo D et al Reference val ues oxygen saturation sea level highest hu man habitation Andes acclimatised persons Thorax 2018 73 776778 Altitude affects mortality Peruvian HD patients 1003 13 Bigham AW Wilson MJ Julian CG et al Andean Tibetan patterns adaptation high altitude Am J Hum Biol 2013 25 190197 20 Miele CH Schwartz AR Gilman RH et al Increased cardiome tabolic risk worsening hypoxemia high altitude High Alt Med Biol 2016 17 93100 14 Beall CM Two routes functional adaptation Tibetan Andean highaltitude natives Proc Natl Acad Sci USA 2007 104 86558660 21 Instituto Nacional Estadıstica e Informa tica Producto Instituto Bruto Interno por Departamentos Lima Peru Nacional Estadıstica e Informa tica 2019 15 Luks AM Johnson RJ Swenson ER Chronic kidney disease high altitude J Am Soc Nephrol 2008 19 22622271 16 Ghahramani N Ahmed F AlLaham A et al The epidemi ological association altitude chronic kidney dis ease evidence protective effect Nephrology Carlton 2011 16 219224 17 Sibbel S Maroni BJ Brunelli SM The effect altitude erythropoiesisstimulating agent dose hemoglobin level mortality hemodialysis patients J Nephrol 2017 30 821829 18 Shapiro BB Streja E Rhee CM et al Revisiting association altitude mortality dialysis patients Hemodial Int 2014 18 374383 19 Vongsanim S Davenport A The effect gender survival hemodialysis patients Why dont women live longer men Semin Dial 2019 32 438443 22 Instituto Nacional Estadıstica e Informa tica Proyecciones Departamentales la Poblacio n 19952015 Evolucio n la Esperanza Vida al Nacer Lima Peru Instituto Nacional Estadıstica e Informa tica 2015 23 Instituto Nacional Estadıstica e Informa tica Genero Equidad y Disparidades Desarrollo Humano y Genero en la Decada Los Noventa Lima Peru Instituto Nacional Estadıstica e Informa tica 2000 24 Consejo Nacional Residentado Me dico Ley N 30453 http wwwconaremeorgpewebprocesodeadmision2010php 23 February 2020 date accessed 25 Instituto Nacional Estadıstica e Informa tica Censo Nacional 2017 XII Poblacio n VII Vivienda y III Comunidades Indıgenas Lima Peru Instituto Nacional Estadıstica e Informa tica 2018